Volker Patzel, chemist, received his Ph.D. from the Ruprecht Karls University in Heidelberg and his MBA from the Steinbeis University in Berlin. He worked as postdoc at the German Cancer Research Centre in Heidelberg and then as research group leader at the Max Planck Institute for Infection Biology in Berlin. Currently he holds a dual appointment as Assistant Professor at the National University of Singapore and Assistant Director of Research at the University of Cambridge. He is founder and director of the Steinbeis Transfer Centre for Nucleic Acids Design. His research focuses on the design and delivery of ribonucleic acids for enhancement, inhibition or repair of gene expression towards diagnostic and therapeutic applications.
Selective killing of virus-transduced or cancer cells using a RNA trans-splicing based suicide gene therapy approachz